home / stock / adil / adil quote
Last: | $1.73 |
---|---|
Change Percent: | 2.34% |
Open: | $1.67 |
Close: | $1.73 |
High: | $1.76 |
Low: | $1.622 |
Volume: | 139,362 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.73 | $1.67 | $1.73 | $1.76 | $1.622 | 139,362 | 04-25-2024 |
$1.71 | $1.65 | $1.71 | $1.76 | $1.62 | 142,940 | 04-24-2024 |
$1.7 | $1.86 | $1.7 | $1.8753 | $1.65 | 439,648 | 04-23-2024 |
$1.9 | $2.02 | $1.9 | $2.05 | $1.8064 | 2,514,202 | 04-22-2024 |
$1.93 | $2.04 | $1.93 | $2.18 | $1.87 | 323,946 | 04-19-2024 |
$2.17 | $2.3 | $2.17 | $2.3 | $2.12 | 153,625 | 04-18-2024 |
$2.32 | $2.24 | $2.32 | $2.46 | $1.7 | 1,209,872 | 04-17-2024 |
$2.24 | $2.6 | $2.24 | $2.62 | $2.2289 | 666,069 | 04-16-2024 |
$2.61 | $2.25 | $2.61 | $3.1 | $2.22 | 3,281,378 | 04-15-2024 |
$2.33 | $2.68 | $2.33 | $2.87 | $2.29 | 2,752,082 | 04-12-2024 |
$2.98 | $2.37 | $2.98 | $3.08 | $2.34 | 37,666,761 | 04-11-2024 |
$2.33 | $2.55 | $2.33 | $2.74 | $1.75 | 106,739,891 | 04-10-2024 |
$1.13 | $1.14 | $1.13 | $1.17 | $1.0978 | 105,071 | 04-09-2024 |
$1.13 | $1.14 | $1.13 | $1.17 | $1.05 | 1,061,601 | 04-08-2024 |
$1.16 | $1.15 | $1.16 | $1.19 | $1.11 | 141,124 | 04-05-2024 |
$1.22 | $1.26 | $1.22 | $1.37 | $1.21 | 257,774 | 04-04-2024 |
$1.24 | $1.27 | $1.24 | $1.2784 | $1.17 | 110,361 | 04-03-2024 |
$1.23 | $1.2 | $1.23 | $1.23 | $1.15 | 103,111 | 04-02-2024 |
$1.23 | $1.29 | $1.23 | $1.3 | $1.16 | 158,404 | 04-01-2024 |
$1.33 | $1.42 | $1.33 | $1.43 | $1.31 | 84,707 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
Adial Pharmaceuticals Inc Company Name:
ADIL Stock Symbol:
NASDAQ Market:
GLEN ALLEN, Va., April 22, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage bioph...
On April 16, 2024, the United States Patent and Trademark Office issued patent number 11957664 to Adial Pharmaceuticals Inc (NASDAQ:ADIL)...
GLEN ALLEN, Va., April 22, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders...